Comprehensive Cancer Center at Wake Forest University

Summary

Comprehensive Cancer Center at Wake Forest University is a medical facility located in undefined, undefined. This center is recognized for care of Brain Tumor, Leukemia, Breast Cancer, Lung Cancer, Lymphoma and other specialties. Comprehensive Cancer Center at Wake Forest University is involved with conducting 620 clinical trials across 387 conditions. There are 29 research doctors associated with this hospital, such as Roy E. Strowd, Glenn J. Lesser, Rakhee Vaidya, and Michael K. Farris.

Top PIs

Clinical Trials running at Comprehensive Cancer Center at Wake Forest University

Breast Cancer

Lung Cancer

Cancer

Ovarian Cancer

Vulvar Cancer

Cervical Cancer

Pancreatic Cancer

Non-Small Cell Lung Cancer

Head and Neck Squamous Cell Carcinoma

Brain Tumor

Pegfilgrastim

for Breast Cancer

The overall purpose of this study is to investigate whether younger subjects report pain with pegfilgrastim (or biosimilar substitution) more often and/or at higher levels (greater intensity) than older subjects.This study will be carried out throughout the course of your chemotherapy treatment, which will be prescribed by your study doctor. Participation in this study will not affect your cancer treatment.

Recruiting

1 award

N/A

7 criteria

Hormone Therapy

for Cardiovascular Health in Breast Cancer Patients

The purpose of this research study is to understand what effect near complete estrogen deprivation (NCED) therapy has on the heart in breast cancer patients. Investigators want to understand if NCED changes how the heart works.

Recruiting

1 award

N/A

11 criteria

Paclitaxel Monitoring

for Cancer

The goals of this prospective, observational cohort study are to determine the feasibility of implementing paclitaxel therapeutic drug monitoring for cancer patients and explore the relationship between paclitaxel drug exposure and the development of neuropathic symptoms. This trial studies if paclitaxel can be consistently measured in the blood of patients with solid tumors undergoing paclitaxel treatment. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Nerve damage is one of the most common and severe side effects of paclitaxel. The ability to consistently measure paclitaxel in the blood may allow doctors to control the dose of paclitaxel, so that enough chemotherapy is given to kill the cancer, but the side effect of nerve damage is reduced.

Recruiting

1 award

N/A

10 criteria